Cargando…
The Role of Angiogenic and Antiangiogenic Factors in the Second Trimester in the Prediction of Preeclampsia in Pregnant Women With Type 1 Diabetes
OBJECTIVE: To assess the association between circulating angiogenic and antiangiogenic factors in the second trimester and risk of preeclampsia in women with type 1 diabetes. RESEARCH DESIGN AND METHODS: Maternal plasma concentrations of placental growth factor (PlGF), soluble fms-like tyrosine kina...
Autores principales: | Holmes, Valerie A., Young, Ian S., Patterson, Christopher C., Maresh, Michael J.A., Pearson, Donald W.M., Walker, James D., McCance, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816852/ https://www.ncbi.nlm.nih.gov/pubmed/23920083 http://dx.doi.org/10.2337/dc13-0944 |
Ejemplares similares
-
Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial
por: McCance, David R, et al.
Publicado: (2010) -
Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial
por: Holmes, Valerie A., et al.
Publicado: (2011) -
Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
por: Furuya, Mitsuko, et al.
Publicado: (2011) -
Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters
por: Wang, Jing, et al.
Publicado: (2020) -
Carbohydrate quantity is more closely associated with glycaemic control than weight in pregnant women with type 1 diabetes: Insights from the Diabetes and Pre‐eclampsia Intervention Trial (DAPIT)
por: Hill, Alyson J., et al.
Publicado: (2022)